Mereo BioPharma Group plc (MREO)
NASDAQ·Healthcare·Biotechnology
$0.31
-0.29%
Mkt Cap $62.52M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$0.83
Range $0.50 – $1.00
Implied Upside
+168.0%
Consensus $0.83 vs current $0.31
NASDAQ·Healthcare·Biotechnology
$0.31
-0.29%
Mkt Cap $62.52M
No recent rating data.
Price Target (10 analysts)
$0.83
Range $0.50 – $1.00
+168.0%
Consensus $0.83 vs current $0.31